|
시장보고서
상품코드
1457957
세계의 세포 표면 마커 검출 시장 : 시장 규모, 점유율 분석, 산업 매출 추정 및 수요 예측(-2030년)Cell Surface Marker Detection Market Share Analysis by Product, Application - Global Industry Revenue Estimation and Demand Forecast to 2030 |
||||||
세계의 세포 표면 마커 검출(Cell Surface Marker Detection) 시장 규모는 2023년 55억 550만 달러였으며, 2030년에는 94억 2,740만 달러에 이를 것으로 예상되며, 예측 기간 동안 8.1%의 CAGR로 추이하며 성장 할 것으로 예상됩니다. 이 산업의 원동력이 되고 있는 것은 정밀의료에 대한 요구 증가, 체외 진단의 수용도의 상승, 처리량과 자동화율을 높이는 기술 진보입니다.
유동 세포 계측기가 시장을 선도
유동 세포 계측기는 2023년 35%로 가장 큰 점유율을 차지했습니다. 이는 주로, 이 방법은 동일한 샘플에서 다수의 파라미터를 측정할 수 있고, 수초 내에 수백만 개의 세포로부터 데이터를 수집할 수 있기 때문입니다.
창약·연구가 가장 급성장하는 용도
창약·연구 분야는 2030년까지 8.4%로 업계에서 가장 급성장합니다. 그 주된 이유는 만성 질환 증가와 그에 따른 의료비의 급증입니다.
한 보고서에 따르면 2000년 미국에서 만성 질환을 1개 이상 가진 사람은 1억 2,000만 명을 넘었습니다. 이 수는 2030년까지 매년 1% 이상 증가합니다.
따라서 2000년부터 2030년 사이에 북미에서 만성질환을 가진 사람의 수는 약 40%, 약 5,000만명 급증하게 됩니다.
북미는 지역 리더
북미는 2023년에는 55%의 점유율을 차지하며, 이 시장의 지역 리더입니다. 이는 기술 진보, 노인 인구 증가, 만성 질환의 이환율 증가로 인한 것입니다.
아시아 태평양이 가장 빠른 성장을 이룹니다.
아시아 태평양은 지난 10년 말까지 가장 빠른 성장을 이룰 것으로 보입니다. 이는 주로 노인 증가와 최근의 약물 및 연구, 특히 유전자 치료의 진보 때문입니다. 또한 CVD, 당뇨병, 암 환자 수가 증가하고 있는 것도 이 업계의 원동력이 되고 있습니다.
인도에서는 암을 앓는 사람의 수가 2021년 약 2,700만명에서 2025년에는 약 3,000만명으로 증가할 것으로 예상됩니다.
세계의 세포 표면 마커 검출(Cell Surface Marker Detection) 시장을 분석했으며, 시장의 기본 구조/최신 정세/주요 촉진·억제 요인/세계 전체 및 지역별·주요 국가 시장 규모 동향 전망(금액 기준, 2017-2030년)/제품별·용도별 상세 동향/현재 시장 경쟁 구도/주요 기업 프로파일 등 정보를 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 산업 전망
- 시장 역학
- 동향
- 성장 촉진 요인
- 억제 요인/과제
- 성장 촉진 요인/억제 요인의 영향 분석
- COVID-19의 영향
- Porter's Five Forces 분석
제6장 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아 태평양 시장
제10장 남미 시장
제11장 중동 및 아프리카(MEA) 시장
제12장 미국 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 진출기업 및 제공 제품 및 서비스 목록
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근의 전략 전개 상황
제30장 기업 프로파일
- Abbott Laboratories
- Becton, Dickinson and Company
- Nihon Kohden Corporation
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Janssen Diagnostics Inc.
- Grifols SA
- Siemens Healthcare
- BioRad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
제31장 부록
LYJ 24.04.16The size of the cell surface marker detection market was USD 5,505.5 million in 2023, and it will touch USD 9,427.4 million by 2030, propelling at a rate of 8.1% during the projection period. The industry is powered by the increase in the requirement for precision medicine, the increase in the acceptance of in vitro diagnostics, and tech advancements that enhance throughput and the automation rate.
Drivers of the Industry
Cell surface markers help in recognizing high-risk patients precisely, enhancing the accuracy of the diagnosis, progressing follow-up policies for people, estimating susceptibility to targeted therapy or immunotherapy, and predicting prognostic outcomes.
Precision medicine is used in the treatment of many subspecialties, mostly in cancer and inherited diseases, for both diagnosis and treatment, using next-gen sequencing.
Precision medicine reduces the cost of care and advances the overall health of people through the use of pharmacogenomics, which uses patient data to create effective and safe plans for the medication of patients.
Precision medicine is a cutting-edge method of altering the approaches to disease prevention and treatment.
It will allow doctors and researchers to predict more precisely the most appropriate treatment with information on the molecular and genetic makeup of the patient, environment, and lifestyle.
Flow Cytometry Instruments Led the Market
The flow cytometry instruments had the largest share, of 35%, in 2023. This is principally because this method can measure numerous parameters in the same sample and collect data from millions of cells within seconds.
Moreover, with this method, any non-uniformity in a uniform cell populace is detected, and it also eliminates all the dead cells or debris when the final data is provided.
Drug Discovery and Research is the Fastest Growing Application
The drug discovery and research category will grow the fastest in the industry, with a rate of 8.4%, by 2030. This is mostly because of the increasing occurrence of chronic ailments and the resulting surge in healthcare spending.
As per a report, in 2000, in the U.S., people with over one chronic condition were over 120 million. This number will increase by over 1% every year till 2030.
Hence, between 2000 and 2030, the number of people in North America with chronic conditions will surge by about 40% or around 50 million individuals.
North America is the Regional Leader
North America was the regional leader of the market, with a 55% share, in 2023, because of the growing count of tech progressions, surging elderly population, and growing incidence of chronic diseases.
In the U.S., there is an increase in the count of citizens aged 65 and more. This share of the elderly people in the total populace will rise to about 24% by 2060 from 15% in 2016.
The aging population is more susceptible to chronic ailments, for example, cardiac conditions, gastrointestinal issues, and cancer. Moreover, the U.S. is the 5th globally for age-standardized rates for all cancers.
APAC To Experience Fastest Growth
APAC will have the fastest growth by the end of this decade. This is mostly due to the increasing number of elderly people and recent advances in drug discovery and research procedures, particularly in gene therapy. The rising populace of patients with CVDs, diabetes, and cancer is also powering the industry.
In India, the number of people suffering from cancer will increase to about 30 million in 2025 from approximately 27 million in 2021.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by region
- 1.4.4. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product (2017-2030)
- 6.3. Market Revenue, by Application (2017-2030)
- 6.4. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.4. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.4. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.4. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.4. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.4. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Abbott Laboratories
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Becton, Dickinson and Company
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Nihon Kohden Corporation
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Thermo Fisher Scientific Inc.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Sysmex Corporation
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Janssen Diagnostics Inc.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Grifols SA
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Siemens Healthcare
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. BioRad Laboratories Inc.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. F. Hoffmann-La Roche Ltd.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
